#GlobalCMTResearchConvention
Join us for a global CMT research convention,
an event to bring together the CMT research community and the CMT patient community
in a single event.
The CMT Research Foundation is laser-focused on delivering treatments and cures for Charcot-Marie-Tooth disease during our lifetime.
The 2021 Global CMT Research Convention will unite researchers, pharma companies, government and patients to discuss and try to find solutions for the most pressing problems in CMT research.
Come learn what the future holds for CMT and how you can help end this disease!
For the Research Community
September 24th
A day for researchers, industry and government agencies to:
SHARE the latest in CMT drug development research
UNITE their voices and streamline their work
EXAMINE the most pressing issues facing CMT drug development
Agenda
Click here to see the full day of event agenda
Jim Wilson, MD, PhD
University of Pennsylvania
Keynote Speaker
Robert "Bob" Baloh, MD, PhD
Roche
Switzerland
Zarife Sahenk, MD, PhD
Nationwide Children’s Hospital
United States
Kleopas Kleopa, MD
Cyprus Institute of Neurology & Genetics
Cyprus
For the Patient Community
September 25th
A day for the patient community to:
LEARN about recent developments and clinical trials in CMT
INTERACT with key research experts
ACT to advance treatments for CMT
Agenda
Click here to see the full day of event agenda
Artie Suckow, PhD
DTx Pharma
Keynote Speaker
Amanda Haidet-Phillips, PhD
Novartis Gene Therapies
United States
David Herrmann, MBBCh
United States
William Motley, MD, DPhil
Flare Therapeutics
United States
Thank You to Our Sponsors!
The Scientific Programming Committee
Marina Kennerson, PhD – Chair
Carla Taveggia, PhD – Vice Chair
Director, Division of Neuroscience Ospedale San Raffaele, Milan, Italy
Charles Abrams, MD, PhD
Professor of Neurology and Rehabilitation
University of Illinois, Chicago (UIC)
Paul August, PhD
Vice President of Biology
Agios Pharmaceuticals
Robert Burgess, PhD
Professor, The Rare and Orphan Disease Center
The Jackson Laboratory
Amanda Haidet-Phillips, PhD
Senior Director, Translational Medicine
Novartis Gene Therapies
Glen Nuckolls, PhD
Program Director, Neurogenetics, Division of Neuroscience
U.S. National Institute of Neurological Disorders and Stroke (NINDS)
Jonathan Sabbagh, PhD
Scientific Portfolio Director
Muscular Dystrophy Association
Tiina Urv, PhD
Program Director, Office of Rare Diseases Research
U.S. National Center for Advancing Translational Sciences (NCATS)